N-Fmoc-O-cycloheptyl-L-serine

N-Fmoc-O-cycloheptyl-L-serine is a serine derivative bearing a bulky cycloheptyl ether that enhances hydrophobic character and steric demand. The Fmoc group enables straightforward solid-phase incorporation. Researchers introduce this residue to modulate local packing, membrane affinity, or steric shielding. Applications include peptidomimetic design, helix-surface tuning, and structure-property relationship studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R2184

Synonyms/Alias:N-Fmoc-O-cycloheptyl-L-serine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C25H29NO5
M.W/Mr.
423.5

N-Fmoc-O-cycloheptyl-L-serine is a synthetic amino acid derivative featuring both an N-terminal 9-fluorenylmethyloxycarbonyl (Fmoc) protecting group and a cycloheptyl substituent on the serine side chain hydroxyl. As a non-natural, structurally modified serine analog, it serves as a valuable building block in peptide chemistry, particularly for the synthesis of peptides and peptidomimetics with enhanced conformational rigidity and altered physicochemical properties. Its unique structure confers utility in the design of novel biomolecules, enabling researchers to probe structure-activity relationships, modulate peptide backbone flexibility, and introduce steric or hydrophobic elements into synthetic sequences.

Peptide Synthesis: In solid-phase peptide synthesis (SPPS), N-Fmoc-O-cycloheptyl-L-serine is employed as a protected amino acid monomer for the stepwise assembly of custom peptides. The Fmoc group provides orthogonal protection, allowing selective deprotection under mild basic conditions, while the cycloheptyl moiety on the serine side chain introduces bulk and hydrophobicity. Incorporation of this derivative enables the generation of peptides with non-canonical residues, which can be instrumental in modulating biological activity, improving resistance to enzymatic degradation, or exploring novel secondary structures.

Peptidomimetic Design: The cycloheptyl-substituted serine residue is frequently utilized in the development of peptidomimetics—molecules that mimic the structure and function of natural peptides but with enhanced stability or altered bioactivity. By replacing the native serine side chain with a cycloheptyl group, researchers can restrict local conformational freedom, influencing backbone torsion angles and potentially stabilizing preferred secondary structures such as turns or helices. This property is particularly valuable in the rational design of enzyme inhibitors, receptor ligands, or molecular probes with improved pharmacological profiles.

Structure-Activity Relationship Studies: The introduction of a bulky, hydrophobic cycloheptyl group at the serine side chain enables systematic investigation of how steric and electronic modifications affect peptide function. By substituting canonical serine with N-Fmoc-O-cycloheptyl-L-serine in peptide libraries, researchers can assess the impact on binding affinity, selectivity, or overall molecular recognition. Such studies are essential for elucidating the fundamental principles governing protein-ligand interactions and for optimizing lead compounds in early-stage drug discovery.

Conformational Constraint Engineering: The use of this protected amino acid allows for the strategic installation of conformational constraints within synthetic peptides. The cycloheptyl substituent imparts steric hindrance and hydrophobic character, which can reduce backbone flexibility and promote the formation of defined secondary structures. These features are advantageous in the design of peptide-based tools for structural biology, molecular recognition assays, or the development of scaffolds with improved biophysical properties.

Analytical and Method Development: N-Fmoc-O-cycloheptyl-L-serine also finds application in the calibration and validation of analytical methods for peptide synthesis and purification. Its distinct mass and chromatographic behavior make it a useful standard for optimizing protocols involving non-natural amino acid incorporation, monitoring coupling efficiency, or evaluating the performance of separation techniques such as high-performance liquid chromatography (HPLC). The compound's unique structural characteristics thus support both fundamental research and technical method development in the peptide sciences.

InChI
InChI=1S/C25H29NO5/c27-24(28)23(16-30-17-9-3-1-2-4-10-17)26-25(29)31-15-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h5-8,11-14,17,22-23H,1-4,9-10,15-16H2,(H,26,29)(H,27,28)/t23-/m0/s1
InChI Key
MXYLCNOQDVGLIT-QHCPKHFHSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicecGMP Peptide ServicePeptide CDMOPeptide Analysis ServicesPeptide Synthesis ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers